BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PIVOTAL TRIAL OF NEW CORONARY MICROCATHETER - "BIOMICS".
The BIOMICS study is a prospective, multi-center evaluation of the safety and effectiveness of the Biosensors Microcatheter in patients undergoing Percutaneous Coronary Intervention (PCI) for the treatment of chronic total occlusions (CTO).
Временные кардиостимуляторы
Постоянные кардиостимуляторы
Проводы временного кардиостимулятора
Домашний мониторинг
Инструменты